Nephros (NEPH) EBIT Margin (2010 - 2026)
Nephros' quarterly EBIT Margin came in at 1.86% in Q1 2026, down 974.0% year-on-year from 0.21% in Q1 2025, and up 388.95% quarter-over-quarter from 0.38% in Q4 2025.
Nephros has reported EBIT Margin for 17 years, with the latest figure at 1.86% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 974.0% year-over-year to 1.86%; the trailing twelve-month figure through Mar 2026 stood at 3.54% (down 144.0% YoY), and the FY2025 full-year result was 6.1%, up 606.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 1.86%, up from 0.38% in the prior quarter.
- The five-year high for EBIT Margin was 11.61% in Q1 2025, with the low at 71.65% in Q1 2022.
- Average EBIT Margin over 5 years is 11.87%, with a median of 5.68% recorded in 2024.
- Year-over-year, EBIT Margin tumbled 3445 bps in 2022 and soared 6338 bps in 2023.
- Tracing NEPH's EBIT Margin over 5 years: stood at 27.09% in 2022, then increased by 26 bps to 19.94% in 2023, then surged by 141 bps to 8.19% in 2024, then sank by 95 bps to 0.38% in 2025, then soared by 389 bps to 1.86% in 2026.
- The last three EBIT Margin figures came in at 1.86% (Q1 2026), 0.38% (Q4 2025), and 6.59% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 30.87% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 1.97% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 34.92% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 20.96% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 4.04% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 20.78% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 13.65% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 2.44% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 10.94% |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn | 1.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86% |
| Dec 31, 2025 | 0.38% |
| Sep 30, 2025 | 6.59% |
| Jun 30, 2025 | 5.61% |
| Mar 31, 2025 | 11.61% |
| Dec 31, 2024 | 8.19% |
| Sep 30, 2024 | 5.86% |
| Jun 30, 2024 | -9.75% |
| Mar 31, 2024 | -5.68% |
| Dec 31, 2023 | -19.94% |
| Sep 30, 2023 | -5.42% |
| Jun 30, 2023 | -12.27% |
| Mar 31, 2023 | -8.28% |
| Dec 31, 2022 | -27.09% |
| Sep 30, 2022 | -53.18% |
| Jun 30, 2022 | -28.56% |
| Mar 31, 2022 | -71.65% |
| Dec 31, 2021 | -26.58% |
| Sep 30, 2021 | -31.11% |
| Jun 30, 2021 | -49.29% |
| Mar 31, 2021 | -37.21% |
| Dec 31, 2020 | -30.81% |
| Sep 30, 2020 | -43.94% |
| Jun 30, 2020 | -101.33% |
| Mar 31, 2020 | -40.57% |
| Dec 31, 2019 | -9.21% |
| Sep 30, 2019 | -22.46% |
| Jun 30, 2019 | -37.59% |
| Mar 31, 2019 | -73.54% |
| Dec 31, 2018 | -45.22% |
| Sep 30, 2018 | -29.64% |
| Jun 30, 2018 | -47.80% |
| Mar 31, 2018 | -114.01% |
| Dec 31, 2017 | -31.00% |
| Sep 30, 2017 | -56.55% |
| Jun 30, 2017 | -81.49% |
| Mar 31, 2017 | -87.68% |
| Dec 31, 2016 | -81.74% |
| Sep 30, 2016 | -156.51% |
| Jun 30, 2016 | -160.51% |
| Mar 31, 2016 | -147.89% |
| Dec 31, 2015 | -262.18% |
| Sep 30, 2015 | -339.69% |
| Jun 30, 2015 | -104.76% |
| Mar 31, 2015 | -152.94% |
| Dec 31, 2014 | -230.99% |
| Sep 30, 2014 | -228.52% |
| Jun 30, 2014 | -144.22% |
| Mar 31, 2014 | -118.82% |
| Dec 31, 2013 | 140.50% |
| Sep 30, 2013 | -145.45% |
| Jun 30, 2013 | -109.22% |
| Mar 31, 2013 | -193.47% |
| Dec 31, 2012 | -126.80% |
| Sep 30, 2012 | -194.75% |
| Jun 30, 2012 | -268.87% |
| Mar 31, 2012 | -154.44% |
| Dec 31, 2011 | -94.82% |
| Sep 30, 2011 | -193.18% |
| Jun 30, 2011 | -93.88% |
| Mar 31, 2011 | -94.86% |
| Dec 31, 2010 | -116.83% |
| Sep 30, 2010 | -63.18% |
| Jun 30, 2010 | -45.24% |